Author Correction: Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs.

Autor: Laham AJ; Department of Medicine, Cancer Research Program, McGill University Health Center, Montreal, Quebec, H4A 3J1, Canada.; College of Medicine, University of Sharjah, Sharjah, 27272, United Arab Emirates.; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates., El-Awady R; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates. relawady@sharjah.ac.ae.; College of Pharmacy, University of Sharjah, Sharjah, 27272, United Arab Emirates. relawady@sharjah.ac.ae., Saber-Ayad M; College of Medicine, University of Sharjah, Sharjah, 27272, United Arab Emirates.; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates., Wang N; Department of Medicine, Cancer Research Program, McGill University Health Center, Montreal, Quebec, H4A 3J1, Canada., Yan G; Department of Medicine, Cancer Research Program, McGill University Health Center, Montreal, Quebec, H4A 3J1, Canada., Boudreault J; Department of Medicine, Cancer Research Program, McGill University Health Center, Montreal, Quebec, H4A 3J1, Canada., Ali S; Department of Medicine, Cancer Research Program, McGill University Health Center, Montreal, Quebec, H4A 3J1, Canada., Lebrun JJ; Department of Medicine, Cancer Research Program, McGill University Health Center, Montreal, Quebec, H4A 3J1, Canada. JJ.Lebrun@mcgill.ca.
Jazyk: angličtina
Zdroj: NPJ precision oncology [NPJ Precis Oncol] 2024 Jul 08; Vol. 8 (1), pp. 141. Date of Electronic Publication: 2024 Jul 08.
DOI: 10.1038/s41698-024-00628-4
Databáze: MEDLINE
Externí odkaz: